Abstract:Purpose/Objective: MR and CT fusion with CT-based dose calculation has become a routine procedure for IMRT treatment planning. The purpose of this study is to investigate the clinical implementation of MRI-based treatment planning (MRI simulation) for prostate cancer. MRI simulation retains the superior soft-tissue contrast for image segmentation while eliminates the potential error in image fusion due to variations in patient position between CT and MRI and uncertainties in localizing the same structures between the two data sets. Furthermore, MRI simulation will avoid redundant CT imaging sessions, which in turn will avoid unnecessary radiation exposure to the patient, reduce treatment cost, and save patient, staff and machine time. Materials/Methods: A 0.23 T open MR scanner (Philips Medical Systems, Cleveland, OH) was used for this study. Patients were scanned in a supine position in an alpha cradle with knee support and foot holder. One axial reference T2-weighted MR image was obtained with three donut-shaped fiducials on the skin to mark the approximate center of the prostate. A saggittal image was obtained through the center of the prostate as depicted on the axial image. The fiducials were then adjusted to mark the isocenter using a set of trackable lasers. The MRI data consisted of 48 slices (3-mm thickness) covering the whole pelvis. Skin marks were then made for daily treatment setup. The MR images were post processed using a gradient distortion correction (GDC) program provided by the vendor. The prostate and other critical structures were contoured and then transferred together with the MRI data to a commercial inverse planning system. Twenty IMRT plans were made using both unit density MRI and CT with the same beam angles, dose constraints and optimization parameters and the resulting plans were compared in terms of isodose distributions and dose volume histograms (DVH). A hybrid plan is generated for both the CT-based plan and the MR-based plan using the leaf sequences and associated MU designed for the corresponding patient plans. The physical phantom is then irradiated using the same leaf sequences to verify the dosimetry accuracy of the treatment plans. Results: Donut shaped fiducial markers worked well in isocenter localization since the center of the fiducial marker could be clearly determined in one MR slice. The CORVUS treatment planning system (version 5.0) allowed dose calculation on both CT and MRI. Small discrepancies (3–5%) in structure volumes were observed between CT and MR due to image resolution and algorithmic differences in volume determination. Small (∼1.5 cm) differences were also found in external contours between CT and MRI due to residual MRI distortion, which resulted in some differences in intensity maps. However, the final dose distributions were equally acceptable based on our clinical criteria (e.g., V95 = 100% of the prescribed target dose, R40 < 35%, R50 < 17% of the rectal volume, etc.). The absolute dose agreed within 3% between measured dose and dose predicted by the planning system in the physical phantom. The BAT ultrasound system was used for daily target localization and a MRI based DRR was used as a reference to assist setup verification. Conclusions: Our results showed that MRI-based simulation meets the accuracy requirement for patient setup, image segmentation, dose calculation and treatment verification for prostate treatment. Commissioning and quality assurance procedures have been developed for MRI simulation and are being implemented clinically for prostate IMRT at this institution.

[Botulinum toxin efficacy in the treatment of patients with spasmodic dysphonia].

Dosimetric Advantage of Combined IMRT for Whole Lung and Abdomen Irradiation for Wilms Tumor

Deep learning-enabled MRI-only photon and proton therapy treatment planning for paediatric abdominal tumours

In vitro evolution of enzymes.

MRI-based IMRT planning for MR-linac: comparison between CT- and MRI-based plans for pancreatic and prostate cancers

Simulating an intra-fraction adaptive workflow to enable PTV margin reduction in MRIgART volumetric modulated arc therapy for prostate SBRT

Magnetic resonance image-guided adaptive radiotherapy enables safe CTV-to-PTV margin reduction in prostate cancer: a cine MRI motion study

Evaluating the Impact of Bowel Gas Variations for Wilms' Tumor in Pediatric Proton Therapy

First patients treated with a 1.5 T MRI-Linac: clinical proof of concept of a high-precision, high-field MRI guided radiotherapy treatment

Dosimetric impact of geometric distortions in an MRI-only proton therapy workflow for lung, liver and pancreas

Influence of twist on vein and PTFE graft hemodynamics: an ex vivo experimental study.

Improving the clinical workflow of a MR-Linac by dosimetric evaluation of synthetic CT

Ribosomally synthesized and post-translationally modified peptide natural product discovery in the genomic era.

The impacts of mid-treatment CBCT-guided patient repositioning on target coverage during lung VMAT

Clinical implementation of MRI simulation for IMRT of prostate cancer

A 1.5 T transverse magnetic field in radiotherapy of rectal cancer: Impact on the dose distribution

Enhancing Delivery Efficiency on the MR-Linac: A Comprehensive Evaluation of Prostate SBRT using VMAT

Delivered dose quantification in prostate radiotherapy using online 3D cine imaging and treatment log files on a combined 1.5T magnetic resonance imaging and linear accelerator system

The utility of multimodality imaging with CT and MRI in defining rectal tumour volumes for radiotherapy treatment planning: a pilot study

Dosimetric comparison of glioblastoma radiotherapy treatment plans on a low-field MRI-guided linear accelerator compared to conventional C-arm linear accelerator

Expression of hepatic vascular stress genes following ischemia/reperfusion and subsequent endotoxemia